| Organism | Feature Type | Feature ID | Info | Relationship | Display | Orthologous Group | Coexpression Group |
|---|---|---|---|---|---|---|---|
| Glycine max | polypeptide | Glyma.03G262200.5.Wm82.a2.v1 | Glyma.03G262200.5 | mRNA | OG0000429 | ||
| Glycine max | polypeptide | Glyma.07G048200.1.Wm82.a2.v1 | Glyma.07G048200.1 | mRNA | PTHR31140:SF4 - B3 DOMAIN-CONTAINING TRANSCRIPTION FACTOR NGA1-RELATED (1 of 4) | OG0000429 | |
| Glycine max | polypeptide | Glyma.07G048200.2.Wm82.a2.v1 | Glyma.07G048200.2 | mRNA | OG0000429 | ||
| Glycine max | polypeptide | Glyma.07G048200.3.Wm82.a2.v1 | Glyma.07G048200.3 | mRNA | OG0000429 | ||
| Glycine max | polypeptide | Glyma.10G076100.1.Wm82.a2.v1 | Glyma.10G076100.1 | mRNA | PTHR31140:SF2 - B3 DOMAIN-CONTAINING TRANSCRIPTION FACTOR VAL3 (1 of 4) | OG0000429 | |
| Glycine max | polypeptide | Glyma.10G204400.1.Wm82.a2.v1 | Glyma.10G204400.1 | mRNA | K09287 - RAV-like factor (RAV) (1 of 5) | OG0000429 | |
| Glycine max | polypeptide | Glyma.16G017100.1.Wm82.a2.v1 | Glyma.16G017100.1 | mRNA | PTHR31140:SF4 - B3 DOMAIN-CONTAINING TRANSCRIPTION FACTOR NGA1-RELATED (1 of 4) | OG0000429 | |
| Glycine max | polypeptide | Glyma.16G017100.2.Wm82.a2.v1 | Glyma.16G017100.2 | mRNA | OG0000429 | ||
| Glycine max | polypeptide | Glyma.16G017100.3.Wm82.a2.v1 | Glyma.16G017100.3 | mRNA | OG0000429 | ||
| Glycine max | polypeptide | Glyma.16G017100.4.Wm82.a2.v1 | Glyma.16G017100.4 | mRNA | OG0000429 |